LONDON BROKER RATINGS: Experian on JPMorgan focus list at 'overweight'
(Alliance News) - The following London-listed shares received analyst recommendations on Thursday morning and on Wednesday: Read More
| Price | 164.20p on 15-12-2025 at 14:33:43 |
|---|---|
| Change | 7.35p 4.69% |
| Buy | 164.50p |
| Sell | 164.15p |
| Last Trade: | Buy 382.00 at 164.20p |
| Day's Volume: | 3,297,672 |
| Last Close: | 156.85p |
| Open: | 158.00p |
| ISIN: | LU1072616219 |
| Day's Range | 156.85p - 165.05p |
| 52wk Range: | 154.00p - 378.50p |
| Market Capitalisation: | £1.65b |
| VWAP: | 162.4224p |
| Shares in Issue: | 1.01b |
B&M (BME) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 382 | 164.20p | Automatic Execution |
14:33:38 - 15-Dec-25 |
| Unknown* | 0 | 164.15p | SI Trade |
14:33:37 - 15-Dec-25 |
| Buy* | 1 | 164.15p | SI Trade |
14:33:37 - 15-Dec-25 |
| Buy* | 1 | 164.20p | SI Trade |
14:33:37 - 15-Dec-25 |
| Buy* | 232 | 164.20p | Automatic Execution |
14:33:37 - 15-Dec-25 |
| Sell* | 300 | 164.15p | Automatic Execution |
14:33:37 - 15-Dec-25 |
| Sell* | 614 | 164.206p | Ordinary |
14:33:14 - 15-Dec-25 |
| Unknown* | 72 | 164.25p | SI Trade |
14:32:57 - 15-Dec-25 |
| Unknown* | 1 | 164.25p | SI Trade |
14:32:57 - 15-Dec-25 |
| Sell* | 528 | 164.20p | Automatic Execution |
14:32:57 - 15-Dec-25 |
B&M (BME) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 4th Dec 2025 10:00 am | RNS | Major Holding in Company - TR1 |
| 28th Nov 2025 11:00 am | RNS | Major Holding in Company - TR1 |
| 26th Nov 2025 9:30 am | RNS | Major Holding in Company TR1 |
| 24th Nov 2025 2:30 pm | RNS | Major Holding in Company- TR1 |
| 20th Nov 2025 4:00 pm | RNS | CEO Purchase of shares |
| 20th Nov 2025 11:00 am | RNS | CEO Purchase of Shares |
| 19th Nov 2025 9:01 am | RNS | CEO Purchase of Shares |
| 19th Nov 2025 9:00 am | RNS | Major Holding in Company TR1 |
| 18th Nov 2025 11:00 am | RNS | CEO Purchase of Shares |
| 18th Nov 2025 10:58 am | RNS | Major Holding in Company- TR1 |